NCT04853940View on ClinicalTrials.gov

Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

January 1, 2022

Conditions

Covid19

Interventions

OTHER

Data collection and clinical testing of subjects

6-months follow-up with clinical testing at 3 and 6 months

Trial Locations (1)

28034

ICU. Ramón y Cajal University Hospital, Madrid

All Listed Sponsors

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT04853940 - Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients | Biotech Hunter | Biotech Hunter